Metal on metal total hip arthroplasty provides the potential improvement in articular wear and the use of large-diameter femoral heads following the prospect for reduction in the risk of dislocation. The purpose of this study was to compare the clinical and radiographic outcomes as well as serum metal ion level between the two different component designs with small and large femoral heads in metal on metal total hip arthroplasty. We studied 39 patients with large head (Magnum®, Biomet; cup size minus 6 mm) and 37 patients with small head (M2a taper®, Biomet; 28 or 32 mm head) of metal on metal total hip arthroplasty between December 2009 to October 2011 with follow-up of 2.1 years (1.0–3.3 years) after surgery. Harris Hip Score, UCLA activity score, EQ-5D, radiographic assessment, and serum cobalt and chromium ion levels were evaluated. Harris Hip Score, UCLA activity score, and EQ-5D were improved after surgery in small and large head groups, however, no significant differences were observed between both groups. Cup inclination was below 50 degree in all prosthesis. No loosening and no osteolysis were observed. Cobalt and chromium ion was not detected before surgery; however, metal ion levels of both groups were increased after surgery in time dependent manner. There was no significant difference between two groups at one year after surgery. One patient in each group showed the increase of cobalt ion level over 7 ppb (15.4 ppb, 12.9 ppb) without any clinical symptom including pain. Cup inclination was 29 degree in both patients and cup anteversion was 38 and 41 degree, respectively. There was no significant difference of ion levels between both groups. No dislocation was observed in large head group while one dislocation occurred in small head group. No patients required the revision surgery. This metal on metal component, especially with large femoral heads, showed the good clinical results at the maximum follow up of 3.3 year after surgery. However, the ion level of two patients increased over 7 ppb and longer follow-up will be needed

The purpose of this study was to prospectively measure serum cobalt and chromium ion levels in patients who had MITCH Resurfacing (Stryker) and to correlate these with acetabular component orientation (anteversion and inclination). Twenty-seven patients were enrolled in the study. Serum ion levels were measured pre-operatively, six weeks, six months, twelve months and twenty-four months post-operatively. Axial CT scans of the pelvis were used to measure cup anteversion and plain radiographs used to measure cup inclination. The median serum cobalt and chromium levels at one year were 14.5 nmol/l (range, 6 nmol/l to 59 nmol/l) and 36 nmol/l (range, 17nmol/l to 63 nmol/l) respectively. The median serum cobalt and chromium levels at two years were 16.5 nmol/l (range, 6 nmol/l to 75 nmol/l) and 37.5 nmol/l (range, 13 nmol/l to 109 nmol/l) respectively. The mean cup inclination was 43° (range, 30° to 60°). The mean cup anteversion was 19° (range, 1° to 47°). There was no clear correlation with cup position and serum ion levels. There was one outlier with slightly elevated chromium (109 nmol/l) in a female with a small head size. All patients at all time points showed serum cobalt and chromium levels below the level indicating a high-risk implant (7 parts per billion or chromium >134 nmol/l and cobalt > 119 nmol/l). Our results show no clear relationship between cup position and serum metal ions in this group of patients with relatively well-positioned components

Despite a large body of literature the optimal choice of bearing surface for total hip arthoplasty (THA) remains controversial. To avoid the brittleness and squeaking noted with ceramic-on-ceramic and the metal ion release associated with metal-on-metal (MOM) articulations, a novel hybrid coupling of ceramic-on-metal (COM) has been introduced. The purpose of this study was to compare changes in serum metal ion levels and the functional performance of COM and MOM bearing combinations. Eighty-six patients (86 hips) undergoing THA between April 2009 and October 2010 were randomized to COM or MOM bearing couplings. All received identical uncemented acetabular shells and femoral components from two experienced surgeons using the same operative technique. Demographic and peri-operative data were recorded. Serum cobalt and chromium levels, renal function and disease specific outcome scores (Oxford Hip, Harris Hip, UCLA activity) were assessed at baseline, 6 and 12 months post-operatively. Patients and outcome assessors remained blinded. Mean age of the total cohort was 62.5 years. Randomization successfully matched groups for age, Body Mass Index, baseline serum Cobalt and Chromium levels, and pre-operative functional performance scores. One-year data is currently available for 25 of 44 COM and 26 of 42 MOM patients. No significant difference in serum cobalt (P value = 0.81) and chromium (P value = 0.66) levels between groups was noted. Improvements in outcome scores (Oxford Hip, Harris Hip, UCLA activity) were equivalent (P values 0.16 – 0.46). At 1-year, COM and MOM hip arthroplasty articulations appear equivalent in terms of function and serum metal ion levels. Data collection out to 5-years post-surgery continues

We retrospectively reviewed the mid term outcome of 88 MoM THA in 84 patients and 21Hip Resurfacing using Recap Magnum bearing surface performed during 2006 – 2009. There were 41 males and 47 females in the THA group and 17 males and 4 females in the Hip Resurfacing group. All procedures were performed through a posterior approach. The average head size for the THR group was 46mm and the cup size was 52mm and the average head size for the resurfacing was 50mm and cup size was 56mm respectively. Median age for the THA group was 60 yrs. (28–73) and for the Resurfacing it was 51.5 yrs. (32–62). Average follow up was 76 months for the THA group and 78 months for the Resurfacing group. Average serum cobalt for the THA and the Resurfacing groups were 53.2nmol/l (119) and 30.85 and the Chromium levels were 82.44nmol/l(134.5) and 67.49 respectively. Eight MRI scans showed abnormal fluid collections suspicious of ARMD in the THA group and 2 showed fluid collection in the Resurfacing group. There were five revisions in the THA group with the tissue diagnosis of ALVAL. In all except one case a well fixed uncemented stem (Taperloc) was retained. In our series Recap Magnum on a Taperloc stem showed 94% survival at five years and therefore we continue to review the cases annually with serum cobalt chromium levels and MRI scans

Introduction:. The clinical significance of serum metal ion levels alone in patients with stemmed MoM hip arthroplasty remains uncertain. This study aims to measure the metal ion levels in patients with unilateral and bilateral hip arthroplasty to see whether or not the patients with bilateral hips have higher metal ions. Patients and Methods. All the patients with bilateral MoM hip arthroplasty were identified from the research database. These patients were then matched with those in a similar age group who had a unilateral hip arthroplasty, but same University of California Los Angeles (UCLA) activity score. The UCLA activity scores along with other hip scores have been previously gathered for all the patients. Both sets of patients then had measurement of serum cobalt and chromium levels. The results were analyzed and compared. Results:. There were a total of 53 patients with bilateral hips and 53 matched patients with unilateral hips. The average serum Cobalt and Chromium levels were 34 nmol/L (range <10–76) and 23 nmol/L (range <10–104) respectively in the bilateral group; and 14 nmol/L (range <10–45) and 21 nmol/L (range <10–57) in the unilateral group. Given that the MHRA (UK) threshold levels deemed clinically significant are 120 nmol/L and 135 nmol/L for Cobalt and Chromium respectively; the results obtained here are not clinically significant. Conclusions:. One would normally expect, with mathematical reasoning, a patient with bilateral hip arthroplasty to have higher serum metal ion levels than a patient with unilateral arthroplasty. However, this study goes to show that it is not the case

Introduction. In a recent study we evaluated the clinical and radiographic long-term results as well as the serum metal concentrations of 105 cementless primary total hip prosthesis, performed between November 1992 and May 1994 with a 28-mm high-carbide-concentration metal-on-metal articulating surfaces. Forty-one patients who had had a total of forty-four arthroplasties were available for follow-up evaluation at a minimum of seventeen years postoperatively. The median serum cobalt concentration of the patients with their hip replacement as the only source of cobalt was 0.7 µg/L (range 0.4–5.1µg/L), showing no significant difference to the previous study after a minimum of 10 years follow-up. We were investigating the systemic dissemination, which in turn, did not show more severe effects, such as carcinogenicity or renal failure. There are many complex issues associated with the analysis of metal ions, including collecting technique, analysis and reporting of the results. At the AAOS in March 2013, the Hip Society mentioned, that systemic ion levels are just one factor in the evaluation and should not be relied upon solely to determine the need for revision surgery. Furthermore, the correlation between cobalt or chromium serum, urin or synovial fluid levels and adverse local tissue reactions is incompletely understood. Patients and Methods. In our present study we evaluated the serum, urin as well as the joint aspirate metal concentrations, of cementless total hip arthroplasties with a high-carbon, metal-on-metal bearing (Metasul®) at a mean of eighteen-years follow-up. We performed a correlation analysis to evaluate the relationship between these values and to determine whether elevated serum metal concentrations are associated with elevated and local metal concentrations and with early failure of metal-on-metal articulations. Results. Spearman correlations evaluated that there was no significant relationship between the serum cobalt or chromium level and the joint aspirate cobalt (r= 0.60, p=0.15) or chromium (r=0.39, p=0.38) concentration, and the urin cobalt (r=0.21, p=0.62) or chromium (r=0.27, p=0.51) level. Additionally we evaluated a positive correlation between the local chromium concentration and the BMI (r=0.53, p= 0.21) and the cup inclination (r=0.24, p=0.64), a negative correlation between the local chrom concentration and the UCLA (r=0.25, p=0.59) and the Harris hip score (r=0.16, p= 0.73), but without a significance. Conclusion. We evaluated the regional dissemination and the local determination in the synovial fluid, which offers better information about wear and local reactions at the components level prior to the occurrence of marked adverse local tissue and therefore is the best predictor for wear related tissue reaction in MOM articulations, even in asymptomatic patients

Background. There are numerous concerns associated with femoral stems that feature a modular neck design, including the potential for corrosion, modular neck fracture, and adverse local tissue reactions. These stems have a higher-than-anticipated rate of failure in registry results, but large single-center cohort studies are lacking. Methods. This is a retrospective, single-surgeon cohort of 133 hips in 119 patients implanted with a single dual-tapered titanium alloy stem with a modular titanium alloy neck (Profemur® Z; Wright Medical Technology, Arlington, TN). Several bearing surface combinations were used, including metal-on-polyethylene, ceramic-on-polyethylene, metal-on-metal, and ceramic-on-ceramic couples. Patients were evaluated at a mean of 4.5 years (range 2.0–9.0 years) with Harris Hip scores (HHS), radiographic analysis, and metal ion testing. Results. Mean HHS were 84.8 points at latest follow-up (range, 30 to 100 points). Five hips were revised during the study period, for an overall Kaplan-Meier survival of 0.881 at 8 years. There was only one modular neck fracture (0.75%), but others demonstrated ALTR or corrosion at the neck-body interface. Mean serum titanium levels were 4.3 ng/dL (range, < 1 to 46 ng/dL), mean serum cobalt levels were 2.5 ng/dL (range, < 0.1 to 30 ng/dL), and mean serum chromium levels were 1.8 ng/dL (range, < 0.1 to 28.4 ng/dL). Overall 9% of hips had serum titanium levels greater than 7 ng/dL, 10% had serum cobalt levels greater than 7 ng/dL, and 4% had serum chromium levels greater than 7 ng/dL. There was substantial variation in serum metal levels among different bearing surface combinations. Conclusions. The Profemur® Z stem offers good clinical results in the majority of patients with a low rate of modular neck fracture, however there is an increased rate of femoral revision at mid-term follow-up consistent with registry results. We urge caution in the use of stem designs with a modular neck as this additional interface creates a site for unique failure mechanisms that do not occur with monolithic stem designs

The articulating surface replacement (ASR) XL stemmed total hip replacement and ASR resurfacing hip systems were recalled by DePuy due to a high prevalence of early failure. The ASR XL has a greater failure rate than the ASR resurfacing, which has been increasingly attributed to wear and corrosion at the taper interface between the female taper surface of the femoral head and the male taper (trunnion) of the femoral stem. The aim of this study was to quantify the prevalence and severity of taper corrosion in retrieved ASR XL hip components. A peer-reviewed subjective corrosion scoring system was used to quantify corrosion in a consecutive series of the 50 ASR XL hip components (head components – n=44; femoral stems – n=6) at our retrieval centre. Bearing surface wear (femoral head and acetabular cup combined) was quantified and a value of <5 microns was defined as low-wearing. Subsequent profilometry analysis was undertaken in the low-wearing hips to quantify material loss from the taper interface. 90% of components showed evidence of corrosion, with at least moderate corrosion observed in 58%. There were 17 low-wearing hips which had a median material loss from the taper interface of 3.51mm. 3. (range: 0.612–9.443). The median linear depth of material loss was 33μm (range: 8.5–78.0). No relationship was observed between taper corrosion and serum cobalt (r=0.204, p=0.2712) or chromium (r=0.146, p=0.432) metal ions. Wear and material loss from metal-on-metal (MoM) hips is associated with pseudotumour formation and adverse soft-tissue reactions. We have shown that taper corrosion is extremely common in failed ASR XL hips and that wear occurs in the same degree of magnitude as at the bearing surface also occurs at the taper interface. Therefore our findings support the emerging concept of ‘taper failure’, whereby the taper is the predominate reason for failure of MoM hips. Future work must determine the relative contributions of the bearing surface and the taper interface to serum cobalt and chromium metal ion levels

Revision of fractured ceramic-on-ceramic total hip replacements with a cobalt-chromium (CoCr) alloy-on-polyethylene articulation can facilitate metallosis and require further expensive revision surgery [1–3]. In the present study, a fifty-two year old male patient suffered from fatal cardiomyopathy after undergoing revision total hip arthroplasty. The patient had received a polyethylene-ceramic acetabular liner and a ceramic femoral head as his primary total hip replacement. The polyethylene-ceramic sandwich acetabular liner fractured in vivo after 58 months and the patient underwent his first revision surgery where he received a Vitamin E stabilized acetabular Polyethylene (PE) liner and a CoCr alloy femoral head with documented synovectomy at that time. After 15 months, the patient was admitted to hospital in cardiogenic shock, with retrieval of the bearing components. Before the second revision surgery, peak serum cobalt levels measured 6,521 μg/L, 78-times greater than serum cobalt levels of 83μg/L associated with cobalt poisoning [4]. Serum titanium levels found in the patient measured 17.5 μg/L) normal, healthy range 0–1.4 μg/L). The retrieved CoCr alloy femoral head had lost a total of 28.3g (24% or an estimated amount of 102 × 10. −9. wear particles (∼2 μm diameter) [1]) within 16 months of in vivo service. Despite initiating a cobalt chelating therapy, the patients' cardiac left ventricular ejection fraction remained reduced at 6%. This was followed by multi-organ failure, and ultimately the patient passed away shortly after being taken off life support. Embedded ceramic particles were found on the backside and articular surfaces of the Vitamin E-stabilized PE acetabular liner. Evidence of fretting wear on the titanium (Ti) alloy acetabular shell was present, possibly explaining the increased serum Ti levels. Scanning electron microscopy and energy dispersive X-ray analyses confirmed Ti alloy transfer on the embedded ceramic particles on the backside PE liner surface and CoCr alloy transfer on the embedded ceramic particles on the articular PE liner surface. A fractured ceramic-on-ceramic total hip replacement should not be revised to a CoCr alloy-on-polyethylene articulation irrespective of concurrent synovectomy [5] as it can cause severe, third-body wear to the CoCr alloy femoral head that can lead to metallosis with fatal, systemic consequences

Introduction:. The addition of neck-stem modularity of femoral components allowed for increased versatility in controlling stability, head center, and limb length in total hip arthroplasty (THA). Recent reports of neck-stem corrosion, complicated by adverse local tissue reaction, have raised concern and prompted further patient evaluation for revision arthroplasty. Methods:. This was a single center, retrospective case series of thirteen hips in twelve patients. The cohort included eight women and four men, with an average age of 69.5 years (range 50–82), who underwent primary THA with a dual-taper femoral component with a titanium alloy stem, cobalt-chromium (CoCr) alloy modular neck and CoCr alloy head. Patients were followed an average of 34.3 months postsurgical (range 24–38.5 months). Each patient underwent serologic studies including metal ion levels, and Metal Artifact Reduction Sequence (MARS) magnetic resonance imaging (MRI) or Ultrasound. All patients were then referred for fluoro-assisted hip aspiration. Four patients underwent revision surgery. Results:. Ten of thirteen hips were symptomatic at the time of evaluation. ESR and CRP were normal in all patients. Serum Cobalt was elevated in 10/12 patients, with an average serum Cobalt level 4.16 mcg/L (range 1.7–9.4). Serum Chromium levels were normal in all patients. MRI was completed in eleven of twelve patients, with abnormal findings consistent with adverse local tissue reaction in nine hips. Three hips were normal by MRI. One patient had an abnormal ultrasound. Hip aspirations were positive in nine hips, negative in three, and indeterminate in one. Asymptomatic hips (3/13) all had elevated cobalt levels, and 2/3 had positive MRI and aspirates. One patient had a normal MRI and a negative aspirate. Of ten symptomatic hips, eight had elevated cobalt. 7/10 had an abnormal MRI, 2/10 a normal MRI, and 1 abnormal Ultrasound. 5/10 had aspirates that were consistent with the MRI. One aspirate was indeterminate. Four symptomatic patients had discrepancies between MRI findings and aspiration (negative MRI with positive aspirate, or vice versa); one patient had normal labs and MRI, but a positive aspirate, and was noted to have extensive adverse local tissue reaction at revision. Discussion:. Patients with dual-taper femoral stems are at risk of neck-stem corrosion and adverse local tissue reactions. The workup of these patients should include serologic studies as well as advanced imaging with MRI or Ultrasound. Hip aspiration may be a useful adjunct in identifying underlying soft tissue destruction in patients with normal or indeterminate labs or advanced imaging

Background:. Higher than expected revision rates have been observed in large bearing metal-on-metal total hip replacements. We have introduced a metal on metal hip screening clinic at our unit and report the results. Methods:. All patients who had a metal-on-metal total hip replacement implanted at our unit were recalled to clinic. Screening consisted of clinical examination, Oxford hip score, radiographs, MARS MRI and serum cobalt/chromium ion levels. MRI scans were graded (Norwich Classification) by a single consultant radiologist who was blinded to the history, examination, and metal levels. Patients were sub-classified into 6 groups, which determined further follow up and were either entered into a regular screening programme or referred to a revision arthroplasty surgeon for a decision on whether revision was required. Results:. A total of 278 patients were identified. Four patients had moved away, 2 refused follow-up and 1 patient had died. This left 271 patients in our cohort, having 299 metal-on-metal hip replacements with a M:F ratio of 1.5:1 and a mean age of 61.9 years (29–87). 59 (21.8%) patients complained of a recent deterioration in symptoms. Sixty seven (24.7%) patients had an abnormal xray appearance of their hip replacement (inclination >50 degrees, loosening, or migration of prosthesis). Of the 232 hips which underwent MARS MRI, 118 (50.9%) were group A (normal appearance), 66 (28.4%) C1 (mild MOM disease), 31 (13.4%) C2 (moderate MOM disease), and 17 (7.3%) C3 (severe MOM disease). One hundred and seventeen (38.9%) had a substantial fluid collection around the hip. Serum cobalt/chromium metal ions were raised in 135 patients (49.5%), 46 of which had one (8.8%) or both (8%) above 7 ppb (chromium >134 nmol/L, cobalt > 119 nmol/L). One hundred and forty nine patients (55%) remained under review in the MOM clinic and 122 (45%, 148 hip replacements) were referred to a revision surgeon for specialist opinion. Of these 21 hips (14.2%) have been revised and a further 14 hips (9.5%) are awaiting revision. In total 64 hips (21.3% of all large head metal on metal hips implanted in our unit) have been revised with a further 22 (7.3%) listed for revision. Of these, 13 were histologically proven to be an ALVAL reaction, 19 had the classic clinical findings of ALVAL (but not histologically confirmed), and 1 was a non-specific reaction to metal wear. 53 patients (19.4%, 56 hips) were completely asymptomatic but had evidence of ALVAL soft tissue reaction on MRI and/or rising metal ion levels – 9 of these hips have already been revised for ALVAL and 6 more listed for revision. Conclusions. Our screening programme has identified 53 (19.6%) asymptomatic patients who have evidence of a suspicious reaction to their metal-on-metal hip replacements. 16 (3%) of these have gone on to revision. We would recommend all patients with a metal-on-metal total hip replacement in situ are fully screened for ARMD regardless of symptoms and metal ion levels

Uncemented metal-on-polyethylene total hip arthroplasties (THAs) have had a modular cobalt-chrome alloy head since their introduction in the early 1980's. Retrieval analysis studies and case reports in the early 1990's first reported corrosion between the femoral stem trunnion (usually titanium alloy) and cobalt-chrome alloy femoral head. However, then this condition seemed to disappear for about two decades? There are now numerous recent case series of this problem after metal-on-polyethylene THA, with a single taper or dual taper modular femoral component. Metal ion elevation, corrosion debris, and effusion are caused by mechanically assisted crevice corrosion (MACC). These patients present with diffuse hip pain, simulating trochanteric bursitis, iliopsoas tendinitis, or even deep infection. Trunnion corrosion, with adverse local tissue reaction, is a diagnosis of exclusion, after infection, loosening, or fracture. The initial lab tests recommended are: ESR, CRP, and serum cobalt and chromium ions. With a metal-on-polyethylene THA, a cobalt level > 1ppb is abnormal. Plain radiographs are usually negative, but may show calcar osteolysis or acetabular erosion or cyst. MARS MRI may be the best imaging study to confirm the diagnosis. Hip aspiration for culture and cell-count may be necessary. The operative treatment is empiric, with debridement, and head exchange with a ceramic head-titanium sleeve (or oxidised zirconium head) placed on the cleaned trunnion. The femoral component may have to be removed if there is “whole trunnion failure”. This usually relieves the symptoms, but the complication rate of this procedure may be high

Introduction. Mechanically assisted crevice corrosion (MACC) in metal-on-polyethylene (MOP) total hip arthroplasty (THA) is of concern, but its prevalence, etiology and natural history are incompletely understood. Methods. From January 2003 to December 2012, 1356 consecutive THA surgeries using a titanium stem, cobalt chromium alloy femoral head, highly crosslinked polyethylene and a tantalum or titanium acetabular shell were performed. Patients were followed at 1 year, and 5 year intervals for surveillance, but also seen earlier if they had symptoms. Any patient with osteolysis or unexplained pain underwent exam, radiographs, CBC, ESR and CRP, as well as serum cobalt (Co) and chromium (Cr) level. MARS MRI was performed if the Co level was > 1 ppb. Results. Symptomatic MACC was present in 39/1356 patients (2.9%). Yearly MACC prevalence ranged from 0 % (0/139, 2005) to 9.9 % (16/162, 2009). 22/39 (56%) patients have undergone revision surgery, and 17/39 (44%) have opted for ongoing surveillance. Of the surveillance patients, serial serum metal ion levels appear to increase over time. Time of symptoms is correlated with tissue necrosis at time of revision. Conclusions. The prevalence of MACC in MOP hips is higher in this cross-sectional study than previously reported. The highest prevalence was found in 2009 with this vendor. Based on how common this finding is in symptomatic patients from 2009, we may consider asking asymptomatic patients to obtain baseline serum ion levels. The goal of our ongoing research is to understand how to avoid permanent soft tissue loss from adverse local tissue reactions caused by MACC

All patients with a MOM THR implanted at our unit were recalled for clinical examination, Oxford hip score, radiographs, MARS MRI and cobalt/chromium ion levels. Patients were sub-classified, determining further follow up: a regular screening programme or referral to a revision arthroplasty surgeon. We identified 299 MOM THR's. 59 patients reported a recent deterioration in symptoms. 67 had an abnormal x-ray. 232 hips underwent MARS MRI: 66 showed mild MOM disease, 31 moderate MOM disease, 17 severe MOM disease. 117 had a substantial fluid collection around the hip. Serum cobalt/chromium ions were raised in 135 patients. 46 had one or both above 7 ppb. 148 THR's were referred to a revision surgeon. 21 have been revised and 14 are awaiting revision. In total 64 hips have been revised. 13 were histologically proven ALVAL, 19 had clinical findings of ALVAL (not histologically confirmed), and 1 non-specific reaction to metal wear. 53 asymptomatic patients had evidence of soft tissue reaction on MRI and/or rising metal ions. Our screening programme identified asymptomatic patients with evidence of a suspicious reaction to their MOM THR. We recommend all patients with a MOM THR are fully screened for ARMD regardless of symptoms and metal ion levels

Introduction. There have been increased concerns with trunnion fretting and corrosion and adverse local tissue reactions (ALTR) in total hip arthroplasty. We report on 11 catastrophic trunnion failures associated with severe ALTR requiring urgent revision arthroplasty. Methods. We retrospectively reviewed 10 patients with gross trunnion failure (n=11) and an additional 3 patients with impending trunnion failure. Results. All patients presented to the emergency department with severe pain, an inability to bear weight, and dramatic radiographs demonstrating implant failure. Patients were an average of 7.8 years from the initial index procedure. Implants were a cementless component with metal on polyethylene bearing from a single manufacturer with a 36mm femoral head size and a range of extended offset of 2.5 to 5.5 and neck length of +0 (n=1), +5 (n=5), and +10 (n=5). The implant was used during a limited time (2.5 years) by single surgeon in our practice using a posterior approach, with the last implant placed 7 years ago. Prior to revision, serum cobalt levels were elevated, typically more than chromium levels. Radiographs demonstrated failure of the implant with a dissociation of the head from the taper and large radiolucent fluid collections from the metal debris (Fig 1). Intraoperative findings and magnetic resonance imaging confirmed a diagnosis of ALTR with loss of abductors, and severe material loss from the taper (Fig 2). We estimate a conservative incidence of catastrophic trunnion failure in our series to be 2.2% (n = 636 total implanted). A femoral revision with a modular Wagner stem was performed, and when necessary the acetabulum was revised secondary to destruction of the locking mechanism from mechanical wear. Discussion and Conclusion. ALTR can occur in patients with catastrophic failure of their trunnion. Radiographs are dramatic. Serum metal ion levels and magnetic resonance imaging is comparable to adverse local tissue reaction in metal on metal bearing surfaces, corrosion at the head neck taper, and corrosion of dual modular taper stems. The initiating events leading to this mechanism of trunnion failure is unknown. We observed trunnion failure at large head sizes and at increased femoral head offsets. Other groups have reported an association of trunnion failure at increased neck length and head size with a variety of manufacturers. Based on our experience, we have been able to identify impending failure based on subtle radiographic criteria and elevated metal ion levels. A failure rate of 2% at 7.8 years is non-trivial. Impending trunnion failure should be considered as a possible diagnosis in a painful total hip arthroplasty with unknown etiology. Serum metal ion levels and magnetic resonance imaging should be obtained as part of the initial evaluation

Introduction. Neck-stem corrosion has been associated with Adverse Local Tissue Reaction (ALTR) in dual-taper femoral stems. Several diagnostic tests, of varying specificity and sensitivity, are used to identify ALTR. The purpose of this study was to document the clinical presentation, diagnostic workup and surgical findings in a large cohort of patients with dual modular stems, and use this information to propose an evaluation protocol that assists surgical decision-making. Methods. This is a single center, single surgeon's retrospective case series of 38 patients who underwent 42 primary total hip arthroplasty (THA) with a dual-taper femoral components between March 2010 and May 2011 The evaluation included clinical exam, hip radiographs, labs including serum metal ion levels, metal artifact reduction sequence magnetic resonance imaging (MARS MRI), and fluoroscopic hip aspiration with qualitative and quantitative assessment of synovial fluid. Each hip aspirate was classified into Class 1 (clear, <10cc), 2(brown, clear, >10cc), or 3 (cloudy, turbid, viscous). 20 patients to date have undergone revision THA. Results. 19/42 hips were symptomatic. Serum cobalt levels were elevated in 38/42 patients. 23/42 had abnormal MRI findings. MRI was able to identify abnormalities in 79% (15/19) of symptomatic patients and 35% (8/23) asymptomatic patients. Class 2 and 3 hip aspirates were associated with abnormal MRI (in 86% and 61%, respectively), elevated Cobalt, and a high rate of revision (71% and 72%, respectively). ESR and CRP were normal in most patients (76% and 66%, respectively). A small subset of patients (2/38) with symptoms, normal metal ion levels and normal MRI, had abnormal aspirates (Class 2 or 3) with extensive tissue necrosis at revision. Conclusion. The diagnosis of ALTR can be challenging and requires integrating data from several sources: clinical exam, radiographs, serum metal testing, MARS MRI and hip aspirations. Hip aspiration appears to be useful not only in excluding infection, as proposed in current literature, but also in identifying ALTR in patients with otherwise normal tests. Abnormal results on MARS MRI and/or hip aspiration appear to be most predictive of surgical pathology. Both should be included in the protocol to evaluate for underlying ALTR in patients with dual-taper femoral stems

Introduction:. Whole blood metal ion level and clinical outcomes of ceramic-on-metal bearing were comparable to ceramic-on-ceramic THA in this prospective randomized controlled trial. Methods:. We randomized 150 consecutive THA cases at one institution into two groups: Group I and Group II. Group I, 75 cases, received a THA using ceramic-on-metal couplings and Group II, 75 cases, received ceramic-on-ceramic bearing THA. The implant differed only in the bearing surfaces used. We compared the serum levels of cobalt (Co) and chromium (Cr) and functional outcome scores preoperatively, and at 2, 6, and 12 months postoperatively. Results:. The demographics and preoperative Co and Cr levels were similar between the groups. Femoral head size measured 32 and 36 mm and the proportion of each size was similar in both groups. The mean serum cobalt and chromium levels increased significantly at 2 months in Group I (Co p = 0.02, Cr p = 0.04), but no differences noted between groups at 6 and 12 months (Co p > 0.05, Cr p > 0.05). The mean WOMAC hip scores showed comparable improvements at 12 months with no difference between groups. No ceramic fracture has occurred during follow-up period. Discussion & Conclusion:. CoM bearing THA has showed the metal ion levels and the clinical results comparable to CoC couples except for the relatively high metal ion in running-in period

Introduction. Corrosion at the modular junction of the femoral component in total hip arthroplasty (THA) was considered as a cause of adverse local tissue reaction in recent years. We reported three adverse local tissue reaction cases after total hip arthroplasty using the same modular neck stem in this study. Materials and Methods. We have been essentially using the same titanium modular neck stem system and the same combination bearing surface of 26mm cobalt chromium (CoCr) head and highly cross linked polyethylene line for primary total hip arthroplasty since November 2009. Three female showed adverse local tissue reaction and had additional surgical treatment after the THA. Results. Two patients showed asymptomatic focal osteolysis on X-ray at the Gruen zone 1 around three years after the THA (one case also showing pseudo tumor around lessor trochanter). One patient presented symptomatic deep vein thrombosis (DVT) suddenly four years after the surgery and was detected massive pseudo tumor around the hip in MRI. High serum cobalt level was detected in two pseud tumor cases (9.3 ng/ml in DVT case, 5.0 ng/ml in an osteolysis case). The patients had debridement of pseudo tumor and osteolysis. The 26mm CoCr head was replaced a delta ceramic head with a new neck and liner. Two osteolysis cases were grafted allogenic bone chips. Pathology specimens showed tissue necrosis. All retrieved head and neck component showed some corrosion only at the modular of head neck junction. High level of cobalt (2.43 mg/100g) and chromium (4.60 mg/100g) were detected in necrotic tissue of DVT case by ICP-MS (Inductively Coupled Plasma-Mass Spectrometry) analysis. Discussion and Conclusion. This study showed adverse local tissue reaction could occur in spite of using small metal head and polyethylene bearing secondary to corrosion at the taper. It is thought that head neck junction corroded due to mechanically assisted crevice corrosion. An incidence of adverse local tissue reaction of this titanium modular stem might be lesser 0.2% (3/2600 over) in our institute. However, we began to stat new combination of bearing surfaces, ceramic head and polyethylene liner, even so extremely low incidence of adverse local tissue reaction derived from cobalt chromium alloy

Hip simulator studies with ceramic-on-metal (COM) predicted less wear than metal-on-metal (MOM: Isaac. 2009). While clinical evidence is scant, two COM case reports described pseudotumors with adverse cup positioning (Deshmukh 2012, Koper 2014). It would appear that our Korean case report is the first to describe pseudotumor formation in well-positioned COM arthroplasty and including detailed failure analysis. A 50-year old female (active salesperson) had bilateral avascular necrosis of her femoral heads. A left metal-on-polyethylene (MPE) hip was performed at outside institution in 2003. At our 3-yrs evaluation, radiographs showed well-functioning MPE hip. Five years later she complained of gradual left-hip pain (2011). Radiographs and CT scan demonstrated wear, osteolysis and loosening of both components. The revision in 2011 was by COM (Fig. 1), using S-ROM stem/sleeve, 36mm ceramic head (Biolox-delta), a CoCr liner and 54mm shell (Pinnacle: Depuy Inc). Cup inclination and anteversion were considered appropriate at 45° and 20° respectively; femoral anteversion of 15° was also appropriate. At 1-yr follow-up patient complained of mild discomfort in left COM hip (2012). Range of motion was painless and normal. Examination revealed a soft, non-tender swelling (2×3cm) in left inguinal region with no inflammation and radiographs were normal (Fig. 1a). One month later the patient complained of left hip pain, the previously noted swelling had increased in size, and she started to limp. Radiographs showed cup migration with increased inclination. CT scans showed a circumscribed lesion extending into iliopsoas region (Fig 2). Serum cobalt and chromium levels were high at 2.4 and 22.5µg/ L, respectively. At revision the pseudotumor and surrounding inflamed synovium was excised. The cystic soft-tissue swelling (stained black) extended into the joint (Fig. 2a). The ceramic head showed a large “black stripe” across the dome (Fig 2b). The cup was loose while the femoral stem was well fixed. Operative cultures of soft tissues and joint fluid were negative for infection while histopathology was consistent for metallosis (Fig. 3). Aggressive debridement was carried out, acetabular defects were filled with bone graft. Revision incorporated 32mm ceramic head (Biolox-delta), highly cross-linked liner and 52mm trabecular-metal shell (Depuy). Functionally the patient has continued to improve. By 6 months, serum ion concentrations decreased to Co:1.3 and Cr:2.54µg/ L with most recent ion levels lower still (Co:0.66 and Cr:0.42µg/ L). Ceramic head surfaces showed normal wear appearance. The large gray stripe identified on the highly polished dome contained Co and Cr metal-transfer from the CoCr liner (Fig. 2b). Thin gray stripes on equatorial head regions (x4 rougher than dome) represented contamination by Ti, Al and V, typical of adverse impingement against Ti6Al4V neck (Clarke 2013). There was a 100–150um defect on rim of CoCr liner as a result of impingement. Cup out-of-roundness was 476um compared to only 7um for ceramic head, thus cup wear dominated at 25–30mm. 3. volume. This case report was illustrative of the unpredictable and seldom diagnosed risk of habitual cup-to-neck impingement and the risk of relying on pristine simulator studies to predict outcomes in novel THA bearings. For any figures or tables, please contact authors directly (see Info & Metrics tab above).

Purpose. There is a postulated association between increased serum metal ions and pseudotumour formation in patients with metal-on-metal hip replacements. The primary aim of this study was to assess the prevalence of pseudotumour in 31 asymptomatic patients with a large femoral head (LFH) metal-on-metal hip implant. This was compared to the prevalence of pseudotumour in 20 matched asymptomatic patients with a hip resurfacing (HRA) and 24 matched asymptomatic patients with a standard metal-on-polyethylene (MOP) total hip. A secondary objective was to assess possible correlation between increased serum metal ions and pseudotumour formation. Method. Ultrasound examination of the three groups was performed at a minimum follow up of two years. Serum metal ions were measured in the metal-on-metal LFH and HRA groups at a minimum of two years. Results. There were 10 (32%) solid or cystic masses in the LFH group with a mean size of 89.3 (8 to 437) cm3. In the HRA group there were five (25%) masses with a mean size of 41.6 (6 to 119) cm3. In the MOP group there was one cystic mass measuring 9.8 cm3. Median serum cobalt and chromium ion levels in the LFH group were 4.50 gL (interquartile range, 2.38 to 7.47) and 2.82 gL (interquartile range, 1.48 to 3.18) compared to 0.83 gL (interquartile range, 0.65 to 1.12) and 1.08 gL (interquartile range, 0.78 to 1.31) in the HRA group. Conclusion. This study demonstrates a significantly higher prevalence of pseudotumours in patients with large head metal-on-metal total hips. The higher levels of metal ions in this group suggest that elevated metal ions may lead to pseudotumour formation